Stevanato Group Investor Presentation

Serving Large Direct Markets with Integrated Solutions $ 15+ Billion Total Addressable Market Across Two Business Segments Biopharma and Diagnostics Solutions Segment Drug Containment Solutions¹ Drug Delivery Systems¹ Engineering Segment IVD Solutions¹ Assembly, Converting, Inspection¹ $ 3.8B $ 2.1B $ 8B $1.6B ~ 7-8% 2022-27 CAGR > 10% 2022-27 CAGR ~ 5-6% ~ 6% 2022-27 CAGR 2022-27 CAGR SG, Core Market SG, Stevanato Group 1Sources: IQVIA; Markets & Markets; Evaluate Pharma; Roots Analysis, Alira Health, Analyst Reports, Expert interviews; SG Internal Data. $15+B in terms of revenue generated by all market participants. Rounded figures. Stevanato Group Investor Presentation, March 2024 17

View entire presentation